Skip to main content
Annals of Neurosciences logoLink to Annals of Neurosciences
. 2026 Jul 9:09727531261461074. Online ahead of print. doi: 10.1177/09727531261461074

Development and Validation of a Customised Yoga Therapy Module for People Living with Early Parkinsonism

Lourdu Mary 1,✉, Prabha Adhikari 2, Udayakumara K 3
PMCID: PMC13354585  PMID: 42436650

Abstract

Background

Parkinson’s disease (PD) is a neurological degenerative condition affecting motor and non-motor functions of everyday life. While early management focuses on functional mobility and rehabilitation, evidence supports that yogic interventions as adjuvant therapy are applied yet limited in clinical practice. This study developed a customised yoga therapy module (CYTM) for motor and non-motor conditions, particularly for people with mild to moderate PD.

Purpose

To develop a patient-friendly, symptom-specific, 24-week CYTM for people living with early Parkinsonism of Hoehn and Yahr staging scale I–III.

Methods

The study follows a five-phased methodological development, which comprises a literature search, conceptualisation and development of a 24-week CYTM for early PD, evaluation with validation by the subject/panel experts, and relevance, along with a phase-wise operational method. The relevance of selected practices was validated with the item-level content validity index (I-CVI) and scale-level (S)-CVI/AVR/UA.

Results

The executed five-phased methodological framework, and the newly developed CYTM comprises 29 practices to improve the functional changes of people with early PD. Experts’ ratings yielded I-CVI (>0.91), scale-level content validity index of the average (S-CVI/AVR) (>0.995) with average and scale-level content validity index based on universal agreement (S-CVI/UA) (Universal Agreement) >0.941.

Conclusion

As per the expert’s opinion, the newly developed, symptom-specific, participant-friendly CYTM could be an appropriate practice for people living with mild to moderate PD. This CYTM will be evaluated by a non-randomised controlled clinical trial to establish its effectiveness.

Keywords: Parkinson’s disease, yoga therapy, symptom-specific, expert opinion, evaluation

Introduction

Parkinson’s disease (PD) is a neurological degenerative condition most commonly defined by motor symptoms, including resting tremor, muscular rigidity, bradykinesia and postural instability. 1 It also encompasses a wide spectrum of non-motor symptoms such as quality of life, cognitive and executive dysfunction, attentional deficits, sleep disturbances and autonomic dysregulation2, 3 affecting the daily activities of older adults. 4 Recent epidemiological data from 2021 estimate that approximately 11.77 million individuals globally are affected by PD, warning a continued rise in prevalence from 2022 to 2035. 5 At this rate, India may contribute to the largest proportion of the global PD burden, with motor symptom onset, between the age group of 22 and 49 years, who are classified as early-onset Parkinson’s disease (EOPD). 6 The general burden of multiple motor and non-motor manifestations can lead to social stigma, self-withdrawal, reduced activities of daily living (ADL) and psychological distress with markedly diminished quality of life (QoL). 7 Though modern medicine has a limitation to respond, many non-pharmacological treatments play a vital role as adjuvant therapy, 8 and one among them is yoga, the ancient Indian traditional and cultural practice, known to be a lifestyle polypill. 9 Evidence suggests that structured yogic interventions, combined with lifestyle modifications, may mitigate PD-associated symptoms, thereby enhancing the overall functional well-being of the geriatric population. 10

Yoga for Early Parkinsonism in Response to Sustainable Development Goals

Sustainable Development Goals (SDGs) present an action plan structure for promoting holistic health among the PD population. 11 SDGs 3.4 and 3.8 support motor and non-motor conditions, enhancing the quality of life. 12 SDG 4.7 facilitates patient and caregiver education in sustainable self-care, while SDG 10.2 promotes low-cost, comprehensive care for elderly individuals in low- and middle-income countries (LMICs). 13 SDG 11.7 encourages the creation of community spaces for active ageing and yoga practice, and SDG 12.8 advocates sustainable health practices.9, 14 In this context, complementary and alternative therapeutic modalities, particularly yogic interventions, are increasingly recognised as valuable adjuncts in PD management. 12 Early integration of asana, pranayama, meditation and other mind-body practices has been shown to mitigate symptom progression and enhance functional outcomes. 15

Need for a Customised Yoga Therapy Module

Existing research demonstrates that yoga enhances postural control, the overall quality and functionality of life in individuals with PD, 16 and interrelated domains influence environmental factors, and lifestyle behaviours.17, 18 Emerging evidence further supports that yoga’s role in improving neuromuscular flexibility, mobility and global functional capacity in PD management.19, 20 However, limitations like short duration, styles and approaches, instructor competency, trial design, tele-yoga delivery and sample size 21 demand a need to develop a culturally aligned, customised practice, particularly for older adults residing in residential care homes.22, 23 The study focuses on developing a customised yoga therapy module (CYTM) to treat both motor and non-motor signs in a clinical setting for early PD, classified as mild to moderate according to the Hoehn and Yahr scale I–III. 24

Methods

The development of a yoga therapy module involves a search of existing literature with an integration of yoga-based interventions in a structured therapeutic framework, with the objective of achieving targeted clinical outcomes. 25 The research team undertook a planning process to design the module to be symptom-specific and participant-friendly. Accordingly, the CYTM was developed using classical yogic texts alongside contemporary empirical evidence, emphasising interventions in modulating PD-related dysfunctions. The development of this existing module for early PD adheres to the 21-item CLARIFY (checklist standardising the reporting of intervention of yoga) checklist 26 given in Supplementary File 1.

Various yogic practices comprising loosening techniques (warm-ups), breathing exercises (pranayama), yoga postures (asana), meditation techniques (dhyana) and yoga-based relaxation (yoga nidra) were systematically selected from classical yoga texts, including Patanjali Yoga Sutra, Hathapradipika, Gheranda Samhita and Hatha Ratnavali, along with modern literature of Yoga Dharshna and Light on Yoga. The module development was executed in a five-phased methodological framework, focusing on creating a comprehensive practical tool for early PD, as shown in Figure 1.

Figure 1. Five-step Methodological Framework for the Development and Validation of the Customized Yoga Therapy Module (CYTM) for Individuals with Early Parkinsonism. The Framework Illustrates the Systematic Process from Literature Search to Phase-wise Practice Formulation.

Figure 1.

Source: Mary et al. 27

Phase 1: Search Strategy for the Literature Review

Eligibility Criteria

The study encompasses randomised controlled trials, clinical trials and experimental studies involving participants aged 60 years and above, diagnosed with PD Hoehn and Yahr stages I–III, from 2015 to 2025 July. Eligible studies must focus on yoga-therapy-based interventions, including mind–body therapy, mindfulness practices, relaxation techniques, breathing exercises and asanas with yoga protocol and development.

Search Strategy

The initial review prioritised older adults with early PD (Hoehn and Yahr I–III) and randomised controlled trials (RCTs)/clinical trials in PubMed and Cochrane Central to match the intended CYTM. The search strategy was developed in PubMed and Cochrane Central. The following Boolean operators are used to search the existing literature, peer-reviewed articles in the PubMed database. The search terms were (‘Yoga’[Mesh] OR ‘Mind-Body Therapies’[Mesh] OR ‘Yoga/therapeutic use’[Mesh] OR ‘Yoga/methods’[Mesh]) AND (‘Parkinson Disease’[Mesh] OR ‘Parkinsonian Disorders’[Mesh]) AND (‘Program Development’[Mesh] OR module OR protocol OR ‘program development’ OR tailored OR selective OR specific OR ‘patient-centered’ OR ‘disease-specific’ OR validation OR ‘content validity’). The same was also carried out in Cochrane Central: Line 1 (Yoga/Mind-body therapies): (‘yoga’ OR ‘mind-body’ OR ‘mind body’ OR ‘mind-body therapy’ OR ‘mind body therapy’). Line 2 (Parkinson’s Disease): (‘parkinson disease’ OR ‘parkinson’s disease’ OR parkinsonian OR parkinsonism OR ‘parkinsonian disorders’). Line 3 (Tailored/Protocol/Program development): (tailored OR protocol OR ‘program development’ OR ‘programme development’ OR ‘patient-centered’ OR ‘patient centred’ OR ‘disease-specific’) and Line 4 combined: #1 AND #2 AND #3. Data were manually reviewed and screened for both the search log and other literature that we came across. Existing work referring to key findings, methodologies, outcomes and critical analysis to identify strengths and gaps in previous research was a first step. Special focus was given to the study outcomes, stages of PD involved, type and duration of yogic methods, incorporating appropriate safety measures, careful designing and methods by which validations were carried. While it is acknowledged that yoga has the potential to alleviate various PD symptoms and boost quality of life, 28 specific therapeutic mechanisms and their extent remain underexplored in scientific literature. Contemporary yogic literature increasingly highlights the health-promoting effects of structured yogic interventions. 29

Phase 2: Conceptualisation and Development of the Proposed Yoga Practice

Conceptualisation

The research team comprised experienced yoga experts and clinical researchers, in collaboration with a qualified medical professional specialised in geriatric care and PD patients. The entire research team together discussed motor and non-motor symptoms of PD. This multidisciplinary dialogue helped in contextualising the clinical manifestation. The development process includes: review of literature, understanding the PD criteria and attention to stakeholders’ opinions specific to the conditions of PD. All medical practitioners, geriatric specialists, pathologists, yoga professors, PD patients, caregivers and alternative health specialists had given their suggestions on the signs and symptoms affecting the routine life of PD people.

Development

The characteristics and symptoms of clinical observations are studied through literature. It explains: balance depends on vestibular, proprioceptive and visual integration and dysfunction increases fall risk. 30 Muscle strength and circulation are interrelated, requiring intact neuromuscular function, sometimes resulting from slowed transit, incontinence and cognitive dysfunction. 31 For each specific case of mentioned PD, therapeutic practices were identified from classical and modern yogic texts. 32 However, the non-motor challenge practices initially demand careful adaptation and progression. Formulating a CYTM specific to the PD symptoms, the module integrated mobilisation techniques like warm-ups aimed at mitigating articular rigidity and enhancing mobility. Standing āsanas were included to promote postural balance and to strengthen hip extensors, quadriceps, hamstrings and calf muscles. 33 Relaxation techniques, pranayama practices including yogic meditation and guided yoga nidra were included to attenuate psychological manifestations commonly connected with PD, like anxiety, stress and depression. 34 These methods were intended to foster neuropsychological stability and promote a calm, integrated state of body and mind.

Phase 3: Evaluation and Validation by the Subject and Panel Experts

The evaluation of the proposed yoga module for individuals with early PD was done in a systemic, multi-stage validation.25, 35 The CYTM was formulated based on the critical parameters of mode, frequency, session duration and progressive therapeutic stages in the framework of standardised therapeutic prescriptions. In order to achieve cognitive diversity and independent judgement, we have used purposive sampling to identify a panel of five experts in the field, including the traditional yoga scholars, interdisciplinary yogic science researchers and experienced practitioners of complementary medicine with advanced academic qualifications, clinical experience (at least 2 years, usually 5+) and multidisciplinary expertise. 36 The completed module, with the justifications of each practice for the targeted PD symptoms, was sent to the experts electronically. The review of each expert was done individually, with a thorough consideration of therapeutic relevance, scientific rigour, safety and clinical applicability to early-stage PD. 25 The functional capacity of the participants, the adequacy of the number and sequence of practices and compatibility with various stages of early PD were taken care of with special attention to focus on neuromuscular facilitation, motor coordination and autonomic control. 37

Validating the Relevance of Selected Practices

The developed CYTM incorporates 29 distinct yoga practices, which were thoroughly reviewed and discussed in terms of their intended purpose and therapeutic application with face validation. The multidisciplinary panel comprising 40 experts, including PD patients, caregivers, geriatricians, doctoral advisory boards, ethical review committee specialists, scientific review board personnel, certified yoga therapists, statisticians, biomedical researchers, bioethicists, risk assessment professionals, legal experts, lay representatives and social scientists, critically appraised and assessed.

Phase 4: Relevance of the Customised Yoga Therapy Module

After the panel validation, the relevance of the practice was once again validated with a linear scale by the interdisciplinary expert team. The qualified yoga therapy specialists and researchers, along with the clinicians from integrative medicine possessing more than 5–10 years of relevant clinical and research experience, were invited via email to complete a structured survey questionnaire administered through Google Forms. The questionnaire was well explained, and we have asked them to rate the relevance of each of the selected yoga practices on a four-point linear scale ([1] as not relevant, [2] as somewhat relevant, [3] as quite relevant, and [4] as highly relevant) for the relevance level of the content validity index of Lynn. 38 The questions were based on the relevance, clarity, simplicity, comprehensibility and the overall suitability for each practice of asana, pranayama, meditation and relaxation was determined with item-level content validity index (I-CVI) and scale-level content validity index of the average (S-CVI/AVR) >0.80–0.90 which is common and scale-level content validity index based on universal agreement (S-CVI/UA), and this is the universal agreement I-CVI = 1.00. Some more questions are added to get their insightful suggestions regarding the identical methods and their application.

Phase 5: Formulation of Phase-wise Operational Practice

Creation of phase-wise operational practice was formulated to ensure dedicated safety evolution for this intervention to ensure participant-friendly and comprehensible practice with chair support, wall support and graduated introduction when necessary. The implementation of operational practice developed for the intervention delineates a methodical administration framework structured through a four-phase progression model. This model is specifically designed to enable the gradual application of therapeutic practices, allowing adequate temporal intervals for participants’ acclimatisation and physiological adaptation. A four-phase progression ensures systematic delivery while accommodating individual variability. The overall developed CYTM phase-wise operational practice is represented in Supplementary File 2. This developed module will be administered through offline mode for a better therapeutic efficacy, comprising a 1-h session–5 days a week over a 24-week intervention period. Preferably, all sessions will be conducted under the supervision of a highly qualified yoga therapist, ensuring therapeutic appropriateness and safety.

Results

Databases were searched from 2015 to 2025, such as PubMed and Cochrane Central. Among 85 identified articles screened by title and abstract, 70 articles were excluded. Fifteen articles were selected for full-text screening; seven were excluded due to incorrect study duration, incorrect study outcome and finally eight articles of Colgrove et al., 12 Ni et al., 39 Kakde et al., 40 Cheung et al., 13 Kwok et al., 41 Walter et al., 18 Adams et al. 42 and Some et al. 19 were helpful in developing the new CYTM. The search results are explained in Supplementary File 3. The design and testing of the yoga module went through the first round of evaluation with feedback and proposals given by subject experts. According to the recommendations of experts, a few changes were made, such as: starting the session with warm-ups, removing four asanas, increasing breath counts (from three to five) and increasing relaxation duration for lasting benefits. The experts gave verbal and written approval with face validation of therapeutic applicability. A panel of 40 experts carried out a rigorous discussion and evaluation of the clinical advantages. This was followed by 11 subject experts of clinical practice for relevance validation. The questions were based on the relevance, clarity, simplicity, comprehensibility and overall suitability, calculated with (I-CVI) ≥0.91 and (S-CVI/AVR) (Average) ≥0.995 and (S-CVI/UA) (Universal Agreement) ≥0.941, (16 out of 17 items had 100% expert agreement) as excellent scores to determine the relevance and applicability of the selected yoga practices in motor and non-motor functions. The executed five-phased methodological framework yielded a 29-practice CYTM for early PD; item- and scale-level content validity metrics are reported in Tables 1 and 2.

Table 1. Proportion of Experts Rating Each Item as Relevant.

Item I-CVI Interpretation
1. Motor symptoms relevance 1.000 Relevant
2. Non-motor symptoms relevance 0.909 Relevant
3–13. All specific yoga practices (items 3–13) relevance 1.000 Relevant
14. Proposed for clinical practice relevance 1.000 Relevant
15. Session duration 45–60 min relevance 1.000 Relevant
16. Breaths per practice 3–5 relevance 1.000 Relevant
17. Frequency 3–5 days/week relevance 1.000 Relevant

Notes: Criteria: 3 (Quite Relevant) or 4 (Highly Relevant) = Relevant. All items have item-level content validity index (I-CVI) ≥ 0.91 (much higher than the recommended threshold of 0.78 for 6–10 experts). Composite results are scale-level content validity index of the average (S-CVI/AVR) (Average) = 0.995. Outstanding and scale-level content validity index based on universal agreement (S-CVI/UA) (Universal Agreement) = 0.941 (16 of 17 items had 100% agreement) as Excellent.

Table 2. Specific Yoga Practices and the Content Validity for Its Relevance.

Item No. Specific Yoga Practice I-CVI Experts Rating Relevant (Out of 11) Interpretation
3. Tadasana, Trikonasana, Ardha Kati Chakrasana (for upper limb rigidity) 1.000 11/11 Excellent
4. Marjalasana, Uttanapadasana, Supta Udarakarshasana, Shava Udarakarshasana (for trunk and lower limb rigidity) 1.000 11/11 Excellent
5. Utkatasana, Vrikshasana (wall support) (for postural balance) 1.000 11/11 Excellent
6. Virabhadrasana (chair if needed), Suryanamaskara (from 3rd month) (for body strength) 1.000 11/11 Excellent
7. Adho Mukha Svanasana (chair if needed), Padottanasana (near wall) (for better circulation) 1.000 11/11 Excellent
8. Pawanmuktasana, Malasana (for constipation) 1.000 11/11 Excellent
9. Makarasana, Bhujangasana, Shalabhasana, Dhanurasana (for urge incontinence and gastrointestinal dysfunction) 1.000 11/11 Excellent
10. Ujjayi and Anuloma-Viloma Pranayama (for breath regulation) 1.000 11/11 Excellent
11. Brahmari, Pranava Dhyana (OM), Soham meditation (for memory and cognition) 1.000 11/11 Excellent
12. Shavasana and Yoga Nidra (for sleep regulation) 1.000 11/11 Excellent
13. Sukhasana, Simhasana and Balasana (for stress and depression relief) 1.000 11/11 Excellent

Notes: Recommended yoga practices and the content validity index were determined following Lynn. 38 The item-level content validity index (I-CVI) was greater than 0.91 to keep the item. The scale-level CVI (S-CVI) was calculated. Scale-level content validity index of the average (S-CVI/AVR): 0.995 or greater is considered excellent. The cut-off 37 CVI: usually ≥0.78 (for ≥6–10 experts). Here, with the 11 experts, scale S-CVI/AVR: 0.995 is generally considered excellent validity. This suggests 100% agreement between the 11 experts on the practice.

Discussion

The module development was executed in a five-phased methodological framework, yielding a preliminary, expert content-validated module for early PD, and a phase progression ensures systematic delivery while accommodating individual variability. Through the literature search, the research team found an existing literature gap and affirmed the necessity to create a CYTM. The validation and relevance results are in line with the previous studies 19 that demonstrated regular yogic sessions have the potential to increase motor proficiency among individuals who are affected by PD through the provision of improved joint mobility and flexibility. 42 Often, practical constraints on the frequency of activities highlight the frequent logistical issues with tele-yoga among the geriatric population and access to online practice.21, 43 In the present study, the yoga regimens for mild and moderate PD were developed based on the existing textbooks and scientific material.25, 44 They are symptom-targeted and participant-specific and were subjected to appropriate statistical tests. Like most other yoga protocols, the module also integrates asanas (poses), pranayama (breathing exercises), meditation and relaxation. 17 As experts suggested, the module will be administered through offline mode for a better therapeutic efficacy, comprising a 1-h session 5 days a week over a 24-week intervention period.

Rigour and Precision of Consensus

The number of people chosen (1–4) for each item, the percentage agreement for ‘relevant’ (3–4), a more stringent ‘4-only’ agreement and 95% binomial CIs for I-CVI are provided. The bootstrap CIs for S-CVI/AVR and S-CVI/UA, and sensitivity by subgroups (e.g., yoga therapists vs clinicians) are also given. The deidentified matrix and analysis outputs are given in the Supplementary File 4.

Sub-group Analysis

This showed a perfect content validity (I-CVI = 1.000, S-CVI/AVR = 1.000, S-CVI/UA = 1.000) in both yoga therapists/researchers/PD caregiver cum yoga therapist (n = 6) and clinicians/integrated-medicine specialists of BNYS/BAMS, MD (n = 5) for all 11 yoga practices portrayed in Figure 2.

Figure 2. Subgroup Sensitivity Analysis Showing Content Validity of Yoga Practices (Items 3–13). Both Subgroups Combining Yoga Therapists/Researchers (n = 6) and Clinicians in Integrated Medicine (n = 5) Demonstrated Perfect Agreement (I-CVI = 1.000, S-CVI/Ave = 1.000, S-CVI/UA = 1.000). This Indicates Robust Content Validity Independent of Professional Background.

Figure 2.

Source: Original analysis and figure by the authors, following Lynn’s (1986) 37 guidelines for content validity. 38

Conclusion

The expert’s opinion-based CYTM is a symptom-specific and participant-friendly first step to the development of an approved daily practice for people with mild to moderate PD. The 29-practice module will be tested on its feasibility with end-users and then evaluated in a non-randomised controlled clinical trial.

Acknowledgements

The authors thank Yenepoya (Deemed to be University), Mangaluru, Karnataka, India. Sincere thanks to the entire department of Geriatric Medicine, Yenepoya Medical College Hospital, Mangaluru. The authors acknowledge and appreciate the support extended by all subject experts for their role in evaluating and validating the yoga module: Dr Subramanya Pailoor, Department of Yoga Studies, CUK; Dr Govardhan Reddy, Division of Yoga, Center for Integrative Medicine Research, Manipal; Dr Rashmitha, Department of Yogic Science and Spirituality, Uttarakhand; Dr Ajitesh, Department of Yoga, Mangalore University College; and Dr Guru Deo, MDNIY, New Delhi. Special thanks to subject experts of clinical practice for validating the relevance of the module. Gratitude is extended to all the panel experts and the Doctoral Advisory Committee members for their meticulous evaluation and constructive recommendations.

The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Funding: The authors received no financial support for the research, authorship and/or publication of this article.

Authors’ Contribution

Study design, methodology and conceptualisation: LM, PA and UK. Developing the original text, collecting data and processing: LM. Interpreting data and analysing, editing and revising the paper: PA and UK.

Clinical Trial Registry of India

The Clinical Trial Registry of India (CTRI) registration: CTRI/2025/07/090595.

Data Availability

The relevance of the chosen practices and their validation are shared along with the manuscript.

Patient Consent

The authors have not included any identifiable individual data or images in this manuscript. This will be addressed in the future.

Statement of Ethics

This study complies with ethical guidelines set by the Indian Council of Medical Research (ICMR) in 2017 and the World Medical Association Declaration of Helsinki (WMA DoH, 2024 Revision), along with the European Medicines Agency Guideline for Good Clinical Practice. The therapeutic developmental model is part of the doctoral research, approved by the Doctoral Advisory Committee (DAC). Institutional Scientific Review Board (SRB) permitted this study with protocol ID: 52112023 for the geriatric concerns, protocol ID: YNYSCH/SRB/RP/01/2023 for the yogic science concerns. The institutional ethical approval is given by (YEC-2), Protocol Number: YEC2/2024/130.

Supplementary Material

Supplementary material for this article is available online.

Supplemental Material for Development and Validation of a Customised Yoga Therapy Module for People Living with Early Parkinsonism by Lourdu Mary Prabha Adhikari and Udayakumara K, in Annals of Neurosciences

References

  • 1.Poewe WH and Wenning GK.. The natural history of Parkinson’s disease. Neurology 1996; 47(6 Suppl. 3): S1–S3. DOI: 10.1212/wnl.47.6_suppl_3.146s [DOI] [PubMed] [Google Scholar]
  • 2.Samii A, Nutt JG, and Ransom BR.. Parkinson’s disease. Lancet 2004; 363(9423): 1783–1793. DOI: 10.1016/s0140-6736(04)16305-8 [DOI] [PubMed] [Google Scholar]
  • 3.Dubois B and Pillon B.. Cognitive deficits in Parkinson’s disease. J Neurol 1996; 244(1): 2–8. DOI: 10.1007/pl00007725 [DOI] [PubMed] [Google Scholar]
  • 4.Lazzarini AM, Zimmerman TR, Mark MH, et al. A clinical genetic study of Parkinson’s disease: evidence for dominant transmission. Neurology 1994; 44(3): 499–506. DOI: 10.1212/wnl.44.3_part_1.499 [DOI] [PubMed] [Google Scholar]
  • 5.Luo Y, Qiao L, Li M, et al. Global, regional, national epidemiology and trends of Parkinson’s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021. Front Aging Neurosci 2024; 16: 1498756. DOI: 10.3389/fnagi.2024.1498756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pal PK. Early onset parkinsonism (EOPD) in India vs. Western populations. Moving Along 2023; 27(2). https://www.movementdisorders.org/MDS/Moving-Along/2023-issue-2/EOPD-in-India-vs-Western-populations [Google Scholar]
  • 7.Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002; 73(6): 629–635. DOI: 10.1136/jnnp.73.6.629 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Al-Worafi Y, editor. Handbook of complementary, alternative, and integrative medicine: education, practice, and research. Volume 5: Disease-focused efficacy and safety . Abingdon (Oxon, UK): Routledge; 2025. DOI: 10.1201/9781003328117 [Google Scholar]
  • 9.Madan S, Sembhi J, Khurana N, et al. Yoga for preventive health: a holistic approach. Am J Lifestyle Med 2023; 17(3): 418–423. DOI: 10.1177/15598276211059758 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jin X, Wang L, Liu S, et al. The impact of mind-body exercises on motor function, depressive symptoms, and quality of life in Parkinson’s disease: a systematic review and meta-analysis. Int J Environ Res Public Health 2020; 17(1): 31. DOI: 10.3390/ijerph17010031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.United Nations. The 17 Goals | Sustainable Development. New York: United Nations; 2025. [cited 15 Jul 2025]. https://sdgs.un.org/goals [Google Scholar]
  • 12.Colgrove Y, Sharma N, Robbins K, et al. A randomized controlled pilot study of the therapeutic effects of yoga in people with Parkinson’s disease. Int J Yoga 2015; 8(1): 74. DOI: 10.4103/0973-6131.146070 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Cheung C, Bhimani R, Wyman JF, et al. Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson’s disease: a pilot randomized controlled trial. Pilot Feasibility Stud 2018; 4: 162. DOI: 10.1186/s40814-018-0355-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gupta P. Yoga at primary health centers—a pathway to holistic health: narrative review. Int J Yoga 2024; 17(2): 93. DOI: 10.4103/ijoy.ijoy_106_24 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jasti N, Bhargav H, Babu H, et al. Challenging case in clinical practice: yoga therapy for Parkinson’s disease. Altern Complement Ther 2020; 26(2): 57–60. DOI: 10.1089/act.2020.29264.nja [Google Scholar]
  • 16.Kwok JYY, Lai CA, Sin WWF, et al. Enhancing whole-person care through mindfulness: qualitative insights from patients with Parkinson’s disease. Mindfulness 2025; 16(8): 2303–2314. DOI: 10.1007/s12671-025-02626-4 [Google Scholar]
  • 17.Mailankody P, Kamble N, Bhattacharya A, et al. Yoga as an add-on therapy in Parkinson’s disease: a single group open-label trial. Can J Neurol Sci 2025; 52(1): 102–109. DOI: 10.1017/cjn.2024.43 [DOI] [PubMed] [Google Scholar]
  • 18.Walter AA, Adams EV, Van Puymbroeck M, et al. Changes in nonmotor symptoms following an 8-week yoga intervention for people with Parkinson’s disease. Int J Yoga Therap 2019; 29(1): 91–99. DOI: 10.17761/2019-00025 [DOI] [PubMed] [Google Scholar]
  • 19.Some P, Vijaykumar PS, Srinivas M, et al. Development and validation of a yoga-based intervention for speech dysfunction and speech difficulties among patients with Parkinson’s disease. Cureus 2024; 16(11): e74215. DOI: 10.7759/cureus.74287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hall E, Verheyden G, and Ashburn A.. Effect of a yoga programme on an individual with Parkinson’s disease: a single-subject design. Disabil Rehabil 2011; 33(15–16): 1483–1489. DOI: 10.3109/09638288.2010.529233 [DOI] [PubMed] [Google Scholar]
  • 21.James-Palmer AM and Daneault JF.. Tele-yoga for the management of Parkinson disease: a safety and feasibility trial. Digit Health 2022; 8: 20552076221119327. DOI: 10.1177/20552076221119327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hoegh M, Ibrahim AK, Chibnall J, et al. Prevalence of Parkinson disease and Parkinson disease dementia in community nursing homes. Am J Geriatr Psychiatry 2013; 21(6): 529–535. DOI: 10.1016/j.jagp.2012.12.007 [DOI] [PubMed] [Google Scholar]
  • 23.Rajyasree A and Balamurugan J.. “Every day is a battle against Parkinson’s”—a qualitative study on older adults at the long-term care facilities in Chennai. Front Public Health 2026; 14. DOI: 10.3389/fpubh.2026.1747471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hoehn MM and Yahr MD.. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17(5): 427–442. DOI: 10.1212/01.wnl.0000405146.06300.91 [DOI] [PubMed] [Google Scholar]
  • 25.Katla N, Ramsahaye A, Thulasi A, et al. Yoga module development and validation: a systematic review with methodological guidelines. Int J Yoga 2022; 15(3): 175–186. DOI: 10.4103/ijoy.ijoy_59_22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Moonaz S, Nault D, Cramer H, et al. CLARIFY 2021: explanation and elaboration of the Delphi-based guidelines for the reporting of yoga research. BMJ Open 2021; 11(8): e045568. DOI: 10.1136/bmjopen-2020-045812 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Mary AL, Adhikari P, Udayakumara K.. Efficacy of a customized yoga therapy module for individuals with early parkinsonism: a non-randomized controlled clinical trial protocol. Complement Med Res 2026; 33(3): 236–245. DOI:10.1159/000551994 [DOI] [PubMed] [Google Scholar]
  • 28.Memarian A, Sanatkaran A, and Bahari SM.. The effect of laughter yoga exercises on anxiety and sleep quality in patients suffering from Parkinson’s disease. Biomed Res Ther 2017; 4(7): 1463. DOI: 10.15419/bmrat.v4i07.200 [Google Scholar]
  • 29.Zhang T, Liu W, Bai Q, et al. The therapeutic effects of yoga in people with Parkinson’s disease: a mini-review. Ann Med 2023; 55(2): 2282475. DOI: 10.1080/07853890.2023.2294935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Leodori G, Santilli M, Modugno N, et al. Postural instability and risk of falls in patients with Parkinson’s disease treated with deep brain stimulation: a stabilometric platform study. Brain Sci 2023; 13(9): 1243. DOI: 10.3390/brainsci13091243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Pfeiffer RF. Autonomic dysfunction in Parkinson’s disease. Neurotherapeutics 2020; 17(4): 1464–1479. DOI: 10.1007/s13311-020-00897-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bhargav H. Yoga for Parkinson’s disease: clinical round up. Focus Altern Complement Ther 2014; 20(3): 50–57. https://www.researchgate.net/publication/290435911_Yoga_for_Parkinson’s_Disease_Clinical_round_up [Google Scholar]
  • 33.Van Puymbroeck M, Walter A, Hawkins BL, et al. Functional improvements in Parkinson’s disease following a randomized trial of yoga. Evid Based Complement Alternat Med 2018; 2018: 8516351. DOI: 10.1155/2018/8516351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sagarwala R and Nasrallah HA.. The effects of yoga on depression and motor function in patients with Parkinson’s disease: a review of controlled studies. Ann Clin Psychiatry 2020; 32(3): 209–215. DOI: 10.1177/104012372003200310 [PubMed] [Google Scholar]
  • 35.More P, Kumar V, Usha Rani MR, et al. Development, validation, and feasibility of a generic yoga-based intervention for Generalized Anxiety Disorder. Complement Ther Med 2021; 63: 102758. DOI: 10.1016/j.ctim.2021.102776 [DOI] [PubMed] [Google Scholar]
  • 36.Justice C, Cheung C, and Samson-Burke A.. Development and evaluation of a yoga intervention program for Parkinson’s disease. Int J Yoga Therap 2018; 28(1): 113–122. DOI: 10.17761/2018-00015r2 [DOI] [PubMed] [Google Scholar]
  • 37.Patidar M, Joshi D, and Nathani N.. Development and content validation of integrated yoga module for patients with essential tremor. Eur J Integr Med 2025; 76: 102463. DOI: 10.1016/j.eujim.2025.102463 [Google Scholar]
  • 38.Lynn MR. Determination and quantification of content validity. Nurs Res 1986; 35(6): 382–385. DOI: 10.1097/00006199-198611000-00017 [PubMed] [Google Scholar]
  • 39.Ni M, Mooney K, and Signorile JF.. Controlled pilot study of the effects of power yoga in Parkinson’s disease. Complement Ther Med 2016; 25: 126–131. DOI: 10.1016/j.ctim.2016.01.007 [DOI] [PubMed] [Google Scholar]
  • 40.Kakde N, Metri KG, Varambally S, et al. Development and validation of a yoga module for Parkinson disease. J Complement Integr Med 2017; 14(3). DOI: 10.1515/jcim-2015-0112 [DOI] [PubMed] [Google Scholar]
  • 41.Kwok JYY, Kwan JCY, Auyeung M, et al. Effects of mindfulness yoga vs stretching and resistance training exercises on anxiety and depression for people with Parkinson disease: a randomized clinical trial. JAMA Neurol 2019; 76(7): 755–763. DOI: 10.1001/jamaneurol.2019.0534 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Adams EV, Van Puymbroeck M, Walter A, et al. Predictors of functional improvements after therapeutic yoga intervention for people with Parkinson’s disease. Int J Yoga Therap 2020; 30(1): 9–18. DOI: 10.17761/2020-d-18-00005 [DOI] [PubMed] [Google Scholar]
  • 43.Ni M, Signorile JF, Mooney K, et al. Comparative effect of power training and high-speed yoga on motor function in older patients with Parkinson disease. Arch Phys Med Rehabil 2016; 97(3): 345–354.e15. DOI: 10.1016/j.apmr.2015.10.095 [DOI] [PubMed] [Google Scholar]
  • 44.Ward L, Nault D, Cramer H, et al. Development of the CLARIFY (CheckList stAndardising the Reporting of Interventions for Yoga) guidelines: a Delphi study. BMJ Open 2022; 12(1): e054902. DOI: 10.1136/bmjopen-2021-054585 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material for this article is available online.

Supplemental Material for Development and Validation of a Customised Yoga Therapy Module for People Living with Early Parkinsonism by Lourdu Mary Prabha Adhikari and Udayakumara K, in Annals of Neurosciences

Data Availability Statement

The relevance of the chosen practices and their validation are shared along with the manuscript.


Articles from Annals of Neurosciences are provided here courtesy of SAGE Publications

RESOURCES